Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 2Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Digestive System Neoplasms 1Desmoid Tumors 1Colorectal Neoplasms 1Adrenocortical Carcinoma 1

Interventions

lutetium Lu 177 dotatate 2gallium Ga 68 dotatate 2Magnetic Resonance Spectroscopy 2Ga(III)-DOTATOC 2lanreotide 1copper dotatate CU-64 1amino-acid, glucose, and electrolyte solution 1X-Rays 1Radiosurgery 1Octreotide 1Nivolumab 1Lutetium-177 1Lutetium 1Ipilimumab 1E-7386 1Disulfides 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gastro-enteropancreatic neuroendocrine tumor × E-7386 × Clear all
NCT03833700 2026-02-27

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Eisai Inc.

Phase 1 Active not recruiting
70 enrolled
EndocrineGastrointestinalNETSarcoma

Gastro-enteropancreatic neuroendocrine tumor, Digestive System Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Desmoid Tumors, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡